Literature DB >> 3257536

Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot.

P J del Nido1, D A Mickle, G J Wilson, L N Benson, R D Weisel, J G Coles, G A Trusler, W G Williams.   

Abstract

Postoperative low cardiac output is the most common cause of death in patients undergoing elective repair of tetralogy of Fallot. The incidence is much higher than in elective adult bypass operations for coronary artery disease. To explain this difference, we investigated 16 children having elective repair of tetralogy (mean age 6.3 years). Myocardial biopsy specimens obtained during bypass before arrest, at the end of cold arrest by blood cardioplegia, and after 30 minutes of reperfusion were studied for adenosine triphosphate and lactate levels. Myocardium was submitted for microscopic study shortly after the onset of ischemia. The operation was successful in reducing right ventricular-pulmonary artery gradients from 82 +/- 28 to 9 +/- 1 mm Hg, yet seven patients required significant inotropic support (dopamine, greater than 5 micrograms/kg/min) for more than 24 hours and 12 patients needed prolonged use of digoxin and diuretics for right ventricular failure. Tissue levels of adenosine triphosphate and lactate in the tetralogy groups were compared with those in 20 adults with coronary artery disease having similar myocardial protection techniques. Adenosine triphosphate levels in the tetralogy group decreased during cross-clamping (41 +/- 8 minutes) from 24 +/- 3 to 16 +/- 2 mmol/kg dry weight (mean +/- 1 standard error), with a marked further drop after reperfusion to 9 +/- 2 mmol/kg (p less than 0.01). Adenosine triphosphate levels in the group with coronary disease also decreased from 20 +/- 1 to 16 +/- 1 mmol/kg after a longer cross-clamp time (70 +/- 17 minutes) but remained at 15 +/- 2 mmol/kg after reperfusion. Tissue lactate levels in the tetralogy group rose markedly during ischemia and remained elevated after reperfusion. In contrast, lactate levels in the group with coronary disease rose moderately during ischemia and returned to normal early on reperfusion. Microscopic study revealed focal myocyte necrosis in tetralogy of Fallot. Our findings, which demonstrate inadequate myocardial protection of patients with tetralogy during repair, with depression of adenosine triphosphate and increased lactate during ischemia and reperfusion, suggest a defect in oxidative metabolism. The drop in adenosine triphosphate after reperfusion in the patients with tetralogy implicates reperfusion injury as a mechanism of myocardial damage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257536

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

Review 1.  Is there a rationale for short cardioplegia re-dosing intervals?

Authors:  Yves D Durandy
Journal:  World J Cardiol       Date:  2015-10-26

2.  Right ventricular diastolic function after repair of tetralogy of Fallot.

Authors:  M S Sachdev; A Bhagyavathy; R Varghese; R Coelho; R S Kumar
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

3.  Controlled reoxygenation cardiopulmonary bypass is associated with reduced transcriptomic changes in cyanotic tetralogy of Fallot patients undergoing surgery.

Authors:  Mohamed T Ghorbel; Amir Mokhtari; Maimuna Sheikh; Gianni D Angelini; Massimo Caputo
Journal:  Physiol Genomics       Date:  2012-09-18       Impact factor: 3.107

Review 4.  Surgical reoxygenation injury of the myocardium in cyanotic patients: clinical relevance and therapeutic strategies by normoxic management during cardiopulmonary bypass.

Authors:  Kiyozo Morita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-07-11

5.  The characterization and purification of a human transcription factor modulating the glutathione peroxidase gene in response to oxygen tension.

Authors:  Frank Merante; Svetlana M Altamentova; Donald A G Mickle; Richard D Weisel; Bradley J Thatcher; Brian M Martin; John G Marshall; Laura C Tumiati; Douglas B Cowan; Ren-Ke Li
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

6.  Management of pulmonic regurgitation and right ventricular dysfunction in the adult with repaired tetralogy of fallot.

Authors:  Elisa Zaragoza-Macias; Karen K Stout
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

7.  Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.

Authors:  K Morita; K Ihnken; G D Buckberg; M P Sherman; H H Young; L J Ignarro
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Effect of orally administered alpha-tocopheryl acetate on human myocardial alpha-tocopherol levels.

Authors:  D A Mickle; R D Weisel; G W Burton; K U Ingold
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

9.  Performance of the chronically hypoxic young rabbit heart.

Authors:  N T Ross-Ascuitto; J J Joyce; A Z M Arif Hasan; R J Ascuitto
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

10.  Cardioplegia in paediatric cardiac surgery: a systematic review of randomized controlled trials.

Authors:  Nigel E Drury; Ivan Yim; Akshay J Patel; Nicola K Oswald; Cher-Rin Chong; John Stickley; Timothy J Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2019-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.